LENZ - NASDAQ

LENZ Therapeutics, Inc.

LENZ·NASDAQ

$7.17

+2.1%

HealthcareBiotechnology

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$224.65M

EPS-2.8500

P/E Ratio-2.51

Earnings Date07/29/2026

lenz

Cash at Beginning of Period

Last Annual Value

20.27M

3-Year CAGR

-62%

5-Year CAGR

408%

10-Year CAGR

95%

Adjust for Inflation

LENZ Therapeutics, Inc. Competitors Analysis of Cash at Beginning of Period

LENZ · NASDAQ

Company	Cash at Beginning of Period	CAGR 3Y	CAGR 5Y	CAGR 10Y
LENZ Therapeutics, Inc. NASDAQ:LENZ	20.27M	-23.0%	0.5%	N/A
Savara Inc. NASDAQ:SVRA	15.13M	-33.8%	-7.9%	-1.0%
Rezolute, Inc. NASDAQ:RZLT	70.40M	-22.4%	47.9%	29.6%
ARS Pharmaceuticals, Inc. NASDAQ:SPRY	50.82M	-37.7%	15.7%	N/A
Arbutus Biopharma Corporation NASDAQ:ABUS	36.33M	5.7%	-7.0%	-14.1%
Geron Corporation NASDAQ:GERN	80.88M	12.2%	51.0%	14.3%
Maravai LifeSciences Holdings, Inc. NASDAQ:MRVI	322.40M	-20.1%	6.4%	N/A
Prime Medicine, Inc. NASDAQ:PRME	196.54M	-0.8%	39.7%	N/A
Tyra Biosciences, Inc. NASDAQ:TYRA	92.97M	-28.2%	43.1%	N/A

LENZ Therapeutics, Inc. Fair Value Envelope

LENZ · NASDAQ

Our analysis suggests that LENZ has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $7.165, this represents a potential HIDDEN relative to our calculated worth for LENZ Therapeutics, Inc..

HIDDEN

Intrinsic Value

Current Price: $7.165

Related Guides

Blog Categories

Continue your LENZ research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.